Allogene takes the stage in New York to go deep on its off-the-shelf cell therapies — declaring a first for solid tumors - Endpoints News
- Allogene takes the stage in New York to go deep on its off-the-shelf cell therapies — declaring a first for solid tumors Endpoints News
- Rare success for Alzheimer's research unlocks hope for future therapies Reuters
- 2 Deaths Linked to Experimental Alzheimer's Treatment Lecanemab Gizmodo
- Drug slows cognitive decline in Alzheimer’s patients, study reveals The Guardian
- Safety concerns hang over new Alzheimer's treatment Axios
- View Full Coverage on Google News